High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants

被引:6
|
作者
Calvo, Andrea [1 ,2 ]
Moglia, Cristina [1 ,2 ]
Canosa, Antonio [1 ,2 ,3 ]
Manera, Umberto [1 ,2 ]
Vasta, Rosario [1 ]
Grassano, Maurizio [1 ]
Daviddi, Margherita [1 ]
De Mattei, Filippo [1 ]
Matteoni, Enrico [1 ]
Gallone, Salvatore [2 ]
Brunetti, Maura [1 ]
Sbaiz, Luca [2 ]
Cabras, Sara [1 ]
Peotta, Laura [1 ]
Palumbo, Francesca [1 ]
Iazzolino, Barbara [1 ]
Mora, Gabriele [1 ]
Chio, Adriano [1 ,2 ,3 ,4 ]
机构
[1] Univ Torino, ALS Ctr, Rita Levi Montalcini Dept Neurosci, Turin, Italy
[2] Azienda Osped Univ Citta Salute & Sci Torino, Neurol 1, Turin, Italy
[3] CNR, Inst Cognit Sci & Technol, Rome, Italy
[4] Univ Torino, Rita Levi Montalcini Dept Neurosci, Via Cherasco 15, I-10126 Turin, Italy
基金
欧盟地平线“2020”;
关键词
REPEAT EXPANSION; ALS; PROFILE; RESERVE; C9ORF72; BRAIN;
D O I
10.1002/ana.26928
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: While the cognitive-behavioral characteristics of amyotrophic lateral sclerosis (ALS) patients carrying C9orf72 pathological repeat expansion have been extensively studied, our understanding of those carrying SOD1 variants is mostly based on case reports. The aim of this paper is to extensively explore the cognitive-behavioral characteristics of a cohort of ALS patients carrying pathogenetic variants of SOD1 gene, comparing them to patients without pathogenetic variants of 46 ALS-related genes (wild-type [WT]-ALS) and healthy controls. Methods: All ALS patients seen at the Turin ALS expert center in the 2009-2021 period who underwent both cognitive/behavioral and extensive genetic testing were eligible to be included in the study. Only patients with SOD1 pathogenetic variants (n = 28) (SOD1-ALS) and WT-ALS (n = 829) were enrolled in the study. A series of 129 controls was also included. Results: Among the 28 SOD1-ALS patients, 16 (57.1%) had normal cognitive function, 5 (17.9%) isolated cognitive impairment (ALSci) (17.9%), 6 (21.4%) isolated behavioral impairment (ALSbi), 1 (3.6%) cognitive and behavioral impairment (ALScbi), and no one ALS-FTD. SOD1-ALS performed worse than controls in all explored domains, in particular Social Cognition and Language domains. SOD1-ALS patients had similar scores in all tests compared to WT-ALS, except the Story-based Empathy Task (SET), where they performed worse. Interpretation: Cognitive-behavioral impairment is much more common in SOD1 patients than previously assumed. SOD1-ALS are characterized by a more frequent impairment of Social Cognition and, less markedly, of Language domains. These findings have relevant implication both in the clinical and in the research setting, also considering recently approved treatment for SOD1-ALS. ANN NEUROL 2024
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [1] Behavioral and Cognitive Phenotypes of Patients With Amyotrophic Lateral Sclerosis Carrying SOD1 Variants
    Dalla Bella, Eleonora
    Bersano, Enrica
    Bruzzone, Maria Grazia
    Gellera, Cinzia
    Pensato, Viviana
    Lauria, Giuseppe
    Consonni, Monica
    NEUROLOGY, 2022, 99 (18) : E2052 - E2062
  • [2] SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis
    P. Wicks
    S. Abrahams
    B. Papps
    A. Al-Chalabi
    C. E. Shaw
    P. N. Leigh
    L. H. Goldstein
    Journal of Neurology, 2009, 256 : 234 - 241
  • [3] SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis
    Wicks, P.
    Abrahams, S.
    Papps, B.
    Al-Chalabi, A.
    Shaw, C. E.
    Leigh, P. N.
    Goldstein, L. H.
    JOURNAL OF NEUROLOGY, 2009, 256 (02) : 234 - 241
  • [4] SOD1 oligomers in amyotrophic lateral sclerosis
    Choi, Esther S.
    Dokholyan, Nikolay, V
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2021, 66 : 225 - 230
  • [5] Neurochemistry of SOD1 and familial amyotrophic lateral sclerosis
    Carrì, MT
    Ceroni, M
    Ferri, A
    Gabbianelli, R
    Casciati, A
    Costa, A
    FUNCTIONAL NEUROLOGY, 2001, 16 (01) : 73 - 82
  • [6] Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant
    Moglia, Cristina
    Calvo, Andrea
    Canosa, Antonio
    Manera, Umberto
    Vasta, Rosario
    Di Pede, Francesca
    Daviddi, Margherita
    Matteoni, Enrico
    Brunetti, Maura
    Sbaiz, Luca
    Cabras, Sara
    Gallone, Salvatore
    Grassano, Maurizio
    Peotta, Laura
    Palumbo, Francesca
    Mora, Gabriele
    Iazzolino, Barbara
    Chio, Adriano
    NEUROLOGY, 2024, 102 (04)
  • [7] Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants
    Bertolin, Cinzia
    D'Ascenzo, Carla
    Querin, Giorgia
    Gaiani, Alessandra
    Boaretto, Francesca
    Salvoro, Cecilia
    Vazza, Giovanni
    Angelini, Corrado
    Cagnin, Annachiara
    Pegoraro, Elena
    Soraru, Gianni
    Mostacciuolo, Maria Luisa
    NEUROBIOLOGY OF AGING, 2014, 35 (05) : 1212.e7 - 1212.e10
  • [8] Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
    Pare, Bastien
    Lehmann, Manuela
    Beaudin, Marie
    Nordstrom, Ulrika
    Saikali, Stephan
    Julien, Jean-Pierre
    Gilthorpe, Jonathan D.
    Marklund, Stefan L.
    Cashman, Neil R.
    Andersen, Peter M.
    Forsberg, Karin
    Dupre, Nicolas
    Gould, Peter
    Brannstrom, Thomas
    Gros-Louis, Francois
    SCIENTIFIC REPORTS, 2018, 8
  • [9] SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis
    Gagliardi, Stella
    Cova, Emanuela
    Davin, Annalisa
    Guareschi, Stefania
    Abel, Kenneth
    Alvisi, Elena
    Laforenza, Umberto
    Ghidoni, Roberta
    Cashman, John Richard
    Ceroni, Mauro
    Cereda, Cristina
    NEUROBIOLOGY OF DISEASE, 2010, 39 (02) : 198 - 203
  • [10] Clinical characterization and founder effect analysis in Chinese amyotrophic lateral sclerosis patients with SOD1 common variants
    Wang, Pei-Shan
    Yang, Xin-Xia
    Wei, Qiao
    Lv, Yong-Ting
    Wu, Zhi-Ying
    Li, Hong-Fu
    ANNALS OF MEDICINE, 2024, 56 (01)